当代医学
噹代醫學
당대의학
CHINA CONTEMPORARY MEDICINE
2013年
12期
8
,共1页
陈瑜%李雪松%皮党育%林悦川
陳瑜%李雪鬆%皮黨育%林悅川
진유%리설송%피당육%림열천
外伤性蛛网膜下隙出血%Rho激酶抑制剂%临床研究
外傷性蛛網膜下隙齣血%Rho激酶抑製劑%臨床研究
외상성주망막하극출혈%Rho격매억제제%림상연구
Traumatic subarachnoid hemorrhage%Rho-kinase inhibitor%clinical research
目的探讨Rho激酶抑制剂对创伤性脑损伤的保护的临床效果.方法选取60例外伤性蛛网膜下隙出血患者,随机分为Rho激酶抑制剂组(简称观察组)和常规治疗组(简称对照组),比较两组临床症状及体征的改善程度及脑血管痉挛的治疗效果.结果观察组在临床症状及体征改善有效率(60%)上明显高于对照组(30%),两组差异具有统计学意义;Rho激酶抑制剂组治疗后(3、5、12 d)双侧大脑中动脉峰值明显低于对照组,两组差异具有统计学意义(P<0.05).结论 Rho激酶抑制剂能有效改善外伤性蛛网膜下隙出血的临床症状及体征,且能有效预防脑血管痉挛的发生.
目的探討Rho激酶抑製劑對創傷性腦損傷的保護的臨床效果.方法選取60例外傷性蛛網膜下隙齣血患者,隨機分為Rho激酶抑製劑組(簡稱觀察組)和常規治療組(簡稱對照組),比較兩組臨床癥狀及體徵的改善程度及腦血管痙攣的治療效果.結果觀察組在臨床癥狀及體徵改善有效率(60%)上明顯高于對照組(30%),兩組差異具有統計學意義;Rho激酶抑製劑組治療後(3、5、12 d)雙側大腦中動脈峰值明顯低于對照組,兩組差異具有統計學意義(P<0.05).結論 Rho激酶抑製劑能有效改善外傷性蛛網膜下隙齣血的臨床癥狀及體徵,且能有效預防腦血管痙攣的髮生.
목적탐토Rho격매억제제대창상성뇌손상적보호적림상효과.방법선취60예외상성주망막하극출혈환자,수궤분위Rho격매억제제조(간칭관찰조)화상규치료조(간칭대조조),비교량조림상증상급체정적개선정도급뇌혈관경련적치료효과.결과관찰조재림상증상급체정개선유효솔(60%)상명현고우대조조(30%),량조차이구유통계학의의;Rho격매억제제조치료후(3、5、12 d)쌍측대뇌중동맥봉치명현저우대조조,량조차이구유통계학의의(P<0.05).결론 Rho격매억제제능유효개선외상성주망막하극출혈적림상증상급체정,차능유효예방뇌혈관경련적발생.
@@@@Objective To investigate the curative effects of application of Rho-kinase inhibitor therapy on protection of traumatic brain injury. Methods 60 patients of traumatic subarachnoid hemorrhage were randomLy divided into two groups:Rho-kinase inhibitor therapy group (observation group)and conventional therapy group (control group), the improvement of clinical symptoms and signs,therapeutic effect of CVS were compared. Results The improvement of clinical symptoms and sign in observation group (60%) were better than those in control group (30%), there was significant difference(P<0.05);the flow rate of cerebral vasoconstriction in middle cerebral artery were also lower in observation group than in control group (P<0.05). Conclusion Rho-kinase in habiting therapy can significantly alleviate cerebral vasospasm following tSAH.